EyePoint Pharmaceuticals Inc

NASDAQ: EYPT
Share price (5/3/24): $19.94
Market cap (5/3/24): $1.039 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

ended 12/31/22 FY 2022

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Adage Capital Management, L.P.

Adage Capital Management, L.P.

Cormorant Asset Management, LP, Chen Bihua, Cormorant Global Healthcare Master Fund, LP

Atchinson Robert, Gross Phillip, Adage Capital Management, L.P.

Paggiarino Dario A.

News Filter

Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments

Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer

Announces First Patient Dosed in Phase 2 VERONA Clinical Trial of EYP-1901 for the Treatment of Diabetic Macular Edema

Announces Proposed Public Offering of Common Stock

Announces Proposed Public Offering of Common Stock

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC